Oragenics INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

AMEX

21 Jan 2026

OGEN

SCHEDULE: Sabby Entities Disclose 9.9% Stake in Oragenics Inc.

Sabby Management, Hal Mintz, and Sabby Volatility Warrant Master Fund, Ltd. have disclosed a combined 9.9% beneficial ownership in Oragenics Inc. common stock.

AMEX

2 Jul 2025

OGEN

Oragenics INC

SCHEDULE: Five Narrow Lane LP Discloses 9.99% Beneficial Ownership in Oragenics, Inc.

Five Narrow Lane LP has filed a Schedule 13G, reporting a 9.99% beneficial ownership stake in Oragenics, Inc., representing 82,210 shares.